Craig Fenwick
Overview
Explore the profile of Craig Fenwick including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
1385
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Correction to: Neutrophil Activation and Immune Thrombosis Profiles Persist in Convalescent COVID‑19
Hocini H, Wiedemann A, Blengio F, Lefebvre C, Cervantes-Gonzalez M, Foucat E, et al.
J Clin Immunol
. 2023 Mar;
43(5):894.
PMID: 36991251
No abstract available.
12.
Hocini H, Wiedemann A, Blengio F, Lefebvre C, Cervantes-Gonzalez M, Foucat E, et al.
J Clin Immunol
. 2023 Mar;
43(5):882-893.
PMID: 36943669
Purpose: Following a severe COVID-19 infection, a proportion of individuals develop prolonged symptoms. We investigated the immunological dysfunction that underlies the persistence of symptoms months after the resolution of acute...
13.
Mathias A, Pantazou V, Perriot S, Canales M, Jones S, Oberholster L, et al.
Neurol Neuroimmunol Neuroinflamm
. 2023 Jan;
10(2).
PMID: 36717268
Background And Objective: Depleting CD20 B cells is the primary mechanism by which ocrelizumab (OCRE) is efficient in persons with multiple sclerosis (pwMS). However, the exact role of OCRE on...
14.
Noto A, Joo V, Mancarella A, Suffiotti M, Pellaton C, Fenwick C, et al.
Viruses
. 2022 Dec;
14(12).
PMID: 36560669
A better understanding of the immunological markers associated with long-lasting immune responses to SARS-CoV-2 infection is of paramount importance. In the present study, we characterized SARS-CoV-2-specific humoral responses in hospitalized...
15.
Noto A, Suffiotti M, Joo V, Mancarella A, Procopio F, Cavet G, et al.
Front Immunol
. 2022 Sep;
13:960120.
PMID: 36091040
Optimal T follicular helper (Tfh) cells function is important to promote the development of germinal centers and maturation of high affinity antigen-specific B cells. We have found that the expression...
16.
Menges D, Zens K, Ballouz T, Caduff N, Llanas-Cornejo D, Aschmann H, et al.
Nat Commun
. 2022 Aug;
13(1):4855.
PMID: 35982045
To better understand the development of SARS-CoV-2-specific immunity over time, a detailed evaluation of humoral and cellular responses is required. Here, we characterize anti-Spike (S) IgA and IgG in a...
17.
Fenwick C, Turelli P, Ni D, Perez L, Lau K, Herate C, et al.
Nat Microbiol
. 2022 Jul;
7(9):1376-1389.
PMID: 35879526
The SARS-CoV-2 Omicron variant has very high levels of transmission, is resistant to neutralization by authorized therapeutic human monoclonal antibodies (mAb) and is less sensitive to vaccine-mediated immunity. To provide...
18.
Munoz O, Banga R, Schelling R, Procopio F, Mastrangelo A, Nortier P, et al.
PLoS Pathog
. 2022 Jul;
18(7):e1010673.
PMID: 35788752
The limited development of broadly neutralizing antibodies (BnAbs) during HIV infection is classically attributed to an inadequate B-cell help brought by functionally impaired T follicular helper (Tfh) cells. However, the...
19.
Pantaleo G, Correia B, Fenwick C, Joo V, Perez L
Nat Rev Drug Discov
. 2022 Jun;
21(9):676-696.
PMID: 35725925
Monoclonal antibodies (mAbs) are appealing as potential therapeutics and prophylactics for viral infections owing to characteristics such as their high specificity and their ability to enhance immune responses. Furthermore, antibody...
20.
Horisberger A, Humbel M, Fluder N, Bellanger F, Fenwick C, Ribi C, et al.
Sci Rep
. 2022 Jun;
12(1):9189.
PMID: 35654865
Determining disease activity in systemic lupus erythematosus (SLE) patients is challenging and limited by the lack of reliable biomarkers. Abnormally activated B cells play a key role in the pathogenesis...